Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.
Kim YH, Park DW, Ahn JM, Yun SC, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Jang Y, Jeong MH, Kim HS, Hur SH, Rha SW, Lim DS, Her SH, Seung KB, Seong IW, Park SJ; PRECOMBAT-2 Investigators. Kim YH, et al. Among authors: jeong mh. JACC Cardiovasc Interv. 2012 Jul;5(7):708-17. doi: 10.1016/j.jcin.2012.05.002. JACC Cardiovasc Interv. 2012. PMID: 22814775 Free article. Clinical Trial.
N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Kwon TG, et al. Among authors: jeong mh. Int J Cardiol. 2009 Apr 3;133(2):173-8. doi: 10.1016/j.ijcard.2007.12.022. Epub 2008 Feb 20. Int J Cardiol. 2009. PMID: 18281115
Stents versus coronary-artery bypass grafting for left main coronary artery disease.
Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Seung KB, et al. Among authors: jeong mh. N Engl J Med. 2008 Apr 24;358(17):1781-92. doi: 10.1056/NEJMoa0801441. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378517 Free article.
A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y. Moon JY, et al. Among authors: jeong mh. Yonsei Med J. 2008 Jun 30;49(3):389-99. doi: 10.3349/ymj.2008.49.3.389. Yonsei Med J. 2008. PMID: 18581587 Free PMC article. Clinical Trial.
Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry.
Lee SH, Kim YJ, Kim W, Park JS, Shin DG, Hur SH, Kim CJ, Cho MC, Chae SC, Jeong MH, Hong TJ, Kim DI, Kim KS; Korean Acute Myocardial Infarction Registry Investigators. Lee SH, et al. Among authors: jeong mh. Circ J. 2008 Sep;72(9):1410-8. doi: 10.1253/circj.cj-08-0088. Circ J. 2008. PMID: 18724014 Free article.
1,412 results